Recent advances in the regulation of cholangiocyte proliferation and function during extrahepatic cholestasis

Digestive and Liver Disease

Volumn 42, Issue 4, 2010, Pages 245-252

  Glaser, Shannon S ^a,b   Onori, Paolo ^f   Wise, Candace ^b   Yang, Fuguan ^b,d   Marzioni, Marco ^e   Alvaro, Domenico ^g   Franchitto, Antonio ^g   Mancinelli, Romina ^g   Alpini, Gianfranco ^a,b,c   Munshi, Md Kamruzzaman ^b   Gaudio, Eugenio ^g  

^a Digestive Disease Research Center   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d CHINA MEDICAL UNIVERSITY   (China)

^e UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^f UNIVERSITY OF L'AQUILA   (Italy)

^g SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Bile duct ligation; Cholangiocyte; Cholestatic liver diseases; Extrahepatic cholestasis; Proliferation

Indexed keywords

ALPHAVBETA6 INTEGRIN; ANGIOGENIC FACTOR; DEATH RECEPTOR 5; ENDOCANNABINOID; EZRIN; GLUCAGON LIKE PEPTIDE 1; HERMES ANTIGEN; HYALURONIC ACID; MOESIN; NEUROPEPTIDE; NEUROTRANSMITTER; PEPTIDE DERIVATIVE; PHOSPHOPROTEIN; PROGESTERONE; RADIXIN; SOMATOMEDIN C; WINGED HELIX TRANSCRIPTION FACTOR;

BILIARY TRACT DISEASE; CELL FUNCTION; CELL GROWTH; CELL NUCLEUS; CELL PROLIFERATION; CELL STRUCTURE; CELL TYPE; CYTOPLASM; DISEASE ACTIVITY; DISEASE COURSE; EPITHELIUM CELL; EXTRAHEPATIC BILE DUCT OBSTRUCTION; GROWTH REGULATION; HUMAN; LIVER CELL; MITOSIS; NEUROENDOCRINE SYSTEM; NEUROTRANSMISSION; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PHENOTYPE; PORTAL HYPERTENSION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; REGULATORY MECHANISM; SHORT SURVEY; STELLATE CELL; STEROIDOGENESIS; TARGET CELL;

ANIMALS; BILE DUCTS; CELL PROLIFERATION; CHOLESTASIS, EXTRAHEPATIC; EPITHELIAL CELLS; HUMANS; LIGATION;

EID: 77649316049     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2010.01.008     Document Type: Short Survey

References (87)

1. Alpini G., Prall R.T., and LaRussoF N.F. The pathobiology of biliary epithelia. In: Arias I.M., Boyer J.L., Chisari F.V., Fausto N., Jakoby W., Schachter D., and Shafritz D.A. (Eds). The liver; biology & pathobiology. 4th edition (2001), Lippincott Williams & Wilkins, Philadelphia, PA 421-435
2. Kanno N., LeSage G., Glaser S., et al. Functional heterogeneity of the intrahepatic biliary epithelium. Hepatology 31 (2000) 555-561
3. Sasaki H., Schaffner F., and Popper H. Bile ductules in cholestasis: morphologic evidence for secretion and absorption in man. Lab Invest 16 (1967) 84-95
4. Nathanson M.H., and Boyer J.L. Mechanisms and regulation of bile secretion. Hepatology 14 (1991) 551-566
5. Alpini G., Lenzi R., Sarkozi L., et al. Biliary physiology in rats with bile ductular cell hyperplasia. Evidence for a secretory function of proliferated bile ductules. J Clin Invest 81 (1988) 569-578
6. Racanelli V., and Rehermann B. The liver as an immunological organ. Hepatology 43 (2006) S54-S62
7. Glaser S., Rodgers R.E., Phinizy J.L., et al. Gastrin inhibits secretin-induced ductal secretion by interaction with specific receptors on rat cholangiocytes. Am J Physiol Gastrointest Liver Physiol 273 (1997) G1061-G1070
8. Glaser S., Francis H., DeMorrow S., et al. Heterogeneity of the intrahepatic biliary epithelium. World J Gastroenterol 12 (2006) 3523-3536
9. Alvaro D., Cho W.K., Mennone A., et al. Effect of secretion on intracellular pH regulation in isolated rat bile duct epithelial cells. J Clin Invest 92 (1993) 1314-1325
10. Alvaro D., Alpini G., Jezequel A.M., et al. Role and mechanisms of action of acetylcholine in the regulation of rat cholangiocyte secretory functions. J Clin Invest 100 (1997) 1349-1362
11. Esteller A. Physiology of bile secretion. World J Gastroenterol 14 (2008) 5641-5649
12. Kanno N., LeSage G., Glaser S., et al. Regulation of cholangiocyte bicarbonate secretion. Am J Physiol Gastrointest Liver Physiol 281 (2001) G612-G625
13. Alpini G., Ulrich II C.D., Phillips J.O., et al. Upregulation of secretin receptor gene expression in rat cholangiocytes after bile duct ligation. Am J Physiol 266 (1994) G922-G928
14. Alpini G., Roberts S., Kuntz S.M., et al. Morphological, molecular, and functional heterogeneity of cholangiocytes from normal rat liver. Gastroenterology 110 (1996) 1636-1643
15. Alpini G., Ulrich C., Roberts S., et al. Molecular and functional heterogeneity of cholangiocytes from rat liver after bile duct ligation. Am J Physiol Gastrointest Liver Dis 272 (1997) G289-G297
16. Glaser S., Gaudio E., Rao A., et al. Morphological and functional heterogeneity of the mouse intrahepatic biliary epithelium. Lab Invest 89 (2009) 456-469
17. LeSage G., Benedetti A., Glaser S., et al. Acute carbon tetrachloride feeding selectively damages large, but not small, cholangiocytes from normal rat liver. Hepatology 29 (1999) 307-319
18. LeSage G., Glaser S., Marucci L., et al. Acute carbon tetrachloride feeding induces damage of large but not small cholangiocytes from BDL rat liver. Am J Physiol Gastrointest Liver Physiol 276 (1999) G1289-G1301
19. Alpini G., Glaser S., Robertson W., et al. Large but not small intrahepatic bile ducts are involved in secretin-regulated ductal bile secretion. Am J Physiol Gastrointest Liver Physiol 272 (1997) G1064-G1074
20. Ueno Y., Alpini G., Yahagi K., et al. Evaluation of differential gene expression by microarray analysis in small and large cholangiocytes isolated from normal mice. Liver Int 23 (2003) 449-459
21. Banales J.M., Arenas F., Rodriguez-Ortigosa C.M., et al. Bicarbonate-rich choleresis induced by secretin in normal rat is taurocholate-dependent and involves AE2 anion exchanger. Hepatology 43 (2006) 266-275
22. Xia X., DeMorrow S., Francis H., et al. Cholangiocyte injury and ductopenic syndromes. Semin Liver Dis 27 (2007) 401-412
23. Schaffner F., and Popper H. Electron microscopic studies of normal and proliferated bile ductules. Am J Pathol 38 (1961) 393-410
24. Ludwig J. New concepts in biliary cirrhosis. Semin Liver Dis 7 (1987) 293-301
25. Gaudio E., Carpino G., Cardinale V., et al. New insights into liver stem cells. Dig Liver Dis 41 (2009) 455-462
26. Gaudio E., Marinozzi G., Carpino F., et al. Scanning electron microscopic stereo views of rat liver following bile duct ligation. Ultramicroscopy 5 (1980) 420
27. Carpino F., Gaudio E., Marinozzi G., et al. A scanning and transmission electron microscopic study of experimental extrahepatic cholestasis in the rat. J Submicrosc Cytol 13 (1981) 581-598
28. Benedetti A., Bassotti C., Rapino K., et al. A morphometric study of the epithelium lining the rat intrahepatic biliary tree. J Hepatol 24 (1996) 335-342
29. Masyuk T.V., Ritman E.L., and LaRusso N.F. Quantitative assessment of the rat intrahepatic biliary system by three-dimensional reconstruction. Am J Pathol 158 (2001) 2079-2088
30. Roskams T., Van den Oord J.J., De Vos R., et al. Neuroendocrine features of reactive bile ductules in cholestatic liver disease. Am J Pathol 137 (1990) 1019-1025
31. Mancinelli R., Onori P., Gaudio E., et al. Follicle-stimulating hormone increases cholangiocyte proliferation by an autocrine mechanism via camp-dependent phosphorylation of ERK1/2 and Elk-1. Am J Physiol Gastrointest Liver Physiol 297 (2009) G11-G26
32. Desmet V., Roskams T., and Van Eyken P. Ductular reaction in the liver. Pathol Res Pract 191 (1995) 513-524
33. Sirica A.E., Gainey T.W., and Mumaw V.R. Ductular hepatocytes. Evidence for a bile ductular cell origin in furan-treated rats. Am J Pathol 145 (1994) 375-383
34. Sirica A.E. Biology of biliary epithelial cells. Prog Liver Dis 10 (1992) 63-87
35. LeSage G., Glaser S., Gubba S., et al. Regrowth of the rat biliary tree after 70% partial hepatectomy is coupled to increased secretin-induced ductal secretion. Gastroenterology 111 (1996) 1633-1644
36. LeSage G., Glaser S., Ueno Y., et al. Regression of cholangiocyte proliferation after cessation of ANIT feeding is coupled with increased apoptosis. Am J Physiol Gastrointest Liver Physiol 281 (2001) G182-G190
37. Alpini G., Glaser S., Ueno Y., et al. Bile acid feeding induces cholangiocyte proliferation and secretion: evidence for bile acid-regulated ductal secretion. Gastroenterology 116 (1999) 179-186
38. LeSage G., Glaser S., and Alpini G. Regulation of cholangiocyte proliferation. Liver 21 (2001) 73-80
39. Francis H., Glaser S., Ueno Y., et al. cAMP stimulates the secretory and proliferative capacity of the rat intrahepatic biliary epithelium through changes in the PKA/Src/MEK/ERK1/2 pathway. J Hepatol 41 (2004) 528-537
40. 2+)-, and protein kinase C alpha-dependent mechanisms. Hepatology 32 (2000) 17-25
41. Strazzabosco M., Fiorotto R., Melero S., et al. Differentially expressed adenylyl cyclase isoforms mediate secretory functions in cholangiocyte subpopulation. Hepatology 50 (2009) 244-252
42. Minagawa N., Nagata J., Shibao K., et al. Cyclic AMP regulates bicarbonate secretion in cholangiocytes through release of ATP into bile. Gastroenterology 133 (2007) 1592-1602
43. Alvaro D., Mancino M.G., Glaser S., et al. Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver. Gastroenterology 132 (2007) 415-431
44. Slott P.A., Liu M.H., and Tavoloni N. Origin, pattern, and mechanism of bile duct proliferation following biliary obstruction in the rat. Gastroenterology 99 (1990) 466-477
45. Azmaiparashvili E., Kordzaia D., and Dzidziguri D. Biliary hypertension as the cell proliferation trigger in bile duct ligated rats. Georgian Med News (2009) 111-116
46. Alpini G., Glaser S., Ueno Y., et al. Heterogeneity of the proliferative capacity of rat cholangiocytes after bile duct ligation. Am J Physiol Gastrointest Liver Physiol 274 (1998) G767-G775
47. 4-induced damage of large cholangiocytes through PI3-kinase-dependent mechanism. Am J Physiol Gastrointest Liver Physiol 284 (2003) G290-G301
48. Glaser S., DeMorrow S., Francis H., et al. Progesterone stimulates the proliferation of female and male cholangiocytes via autocrine/paracrine mechanisms. Am J Physiol Gastrointest Liver Physiol 295 (2008) G124-G136
49. Glaser S., Gaudio E., Miller T., et al. Cholangiocyte proliferation and liver fibrosis. Expert Rev Mol Med 11 (2009) e7
50. Marzioni M., Fava G., and Benedetti A. Nervous and neuroendocrine regulation of the pathophysiology of cholestasis and of biliary carcinogenesis. World J Gastroenterol 12 (2006) 3471-3480
51. Tippins J.R. CGRP: a novel neuropeptide from the calcitonin gene is the most potent vasodilator known. J Hypertens Suppl 4 (1986) S102-S105
52. Wimalawansa S.J. Calcitonin gene-related peptide and its receptors: molecular genetics, physiology, pathophysiology, and therapeutic potentials. Endocr Rev 17 (1996) 533-585
53. Glaser S., Ueno Y., DeMorrow S., et al. Knockout of alpha-calcitonin gene-related peptide reduces cholangiocyte proliferation in bile duct ligated mice. Lab Invest 87 (2007) 914-926
54. Hou Y.F., Zhou Y.C., Zheng X.X., et al. Modulation of expression and function of toll-like receptor 3 in A549 and H292 cells by histamine. Mol Immunol 43 (2006) 1982-1992
55. Jancso G., Santha P., Horvath V., et al. Inhibitory neurogenic modulation of histamine-induced cutaneous plasma extravasation in the pigeon. Regul Pept 95 (2000) 75-80
56. Parsons M.E., and Ganellin C.R. Histamine and its receptors. Br J Pharmacol 147 Suppl. 1 (2006) S127-S135
57. Francis H., Franchitto A., Ueno Y., et al. H3 histamine receptor agonist inhibits biliary growth of BDL rats by downregulation of the cAMP-dependent PKA/ERK1/2/Elk-1 pathway. Lab Invest 87 (2007) 473-487
58. Drucker D.J. Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis. Mol Endocrinol 17 (2003) 161-171
59. Bulotta A., Hui H., Anastasi E., Bertolotto, et al. Cultured pancreatic ductal cells undergo cell cycle re-distribution and beta-cell-like differentiation in response to glucagon-like peptide-1. J Mol Endocrinol 29 (2002) 347-360
60. Marzioni M., Alpini G., Saccomanno S., et al. Glucagon-like peptide-1 and its receptor agonist exendin-4 modulate cholangiocyte adaptive response to cholestasis. Gastroenterology 133 (2007) 244-255
61. Marzioni M., Alpini G., Saccomanno S., et al. Exendin-4, a glucagon-like peptide 1 receptor agonist, protects cholangiocytes from apoptosis. Gut 58 (2009) 990-997
62. Ulloa-Aguirre A., Uribe A., Zarinan T., et al. Role of the intracellular domains of the human FSH receptor in G(alphas) protein coupling and receptor expression. Mol Cell Endocrinol 260-262 (2007) 153-162
63. Larrivee B., and Karsan A. Signaling pathways induced by vascular endothelial growth factor. Int J Mol Med 5 (2000) 447-456 [review]
64. Larrivee B., Lane D.R., Pollet I., et al. Vascular endothelial growth factor receptor-2 induces survival of hematopoietic progenitor cells. J Biol Chem 278 (2003) 22006-22013
65. Gaudio E., Barbaro B., Alvaro D., et al. Vascular endothelial growth factor stimulates rat cholangiocyte proliferation via an autocrine mechanism. Gastroenterology 130 (2006) 1270-1282
66. Gaudio E., Barbaro B., Alvaro D., et al. Administration of r-VEGF-A prevents hepatic artery ligation-induced bile duct damage in bile duct ligated rats. Am J Physiol Gastrointest Liver Physiol 291 (2006) G307-G317
67. Marzioni M., Ueno Y., Glaser S., et al. Cytoprotective effects of taurocholic acid feeding on the biliary tree after adrenergic denervation of the liver. Liver Int 27 (2007) 558-568
68. Marzioni M., LeSage G., Glaser S., et al. Taurocholate prevents the loss of intrahepatic bile ducts due to vagotomy in bile duct-ligated rats. Am J Physiol Gastrointest Liver Physiol 284 (2003) G837-G852
69. Ueno Y., Francis H., Glaser S., et al. Taurocholic acid feeding prevents tumor necrosis factor-alpha-induced damage of cholangiocytes by a PI3k-mediated pathway. Exp Biol Med (Maywood) 232 (2007) 942-949
70. Mancinelli R., Onori P., Gaudio E., et al. Taurocholate feeding to bile duct ligated rats prevents caffeic acid-induced bile duct damage by changes in cholangiocyte VEGF expression. Exp Biol Med (Maywood) 234 (2009) 462-474
71. Jimenez W. Endocannabinoids and liver disease. Hepatology 41 (2005) 983-985
72. DeMorrow S., Francis H., Gaudio E., et al. Anandamide inhibits cholangiocyte hyperplastic proliferation via activation of thioredoxin 1/redox factor 1 and AP-1 activation. Am J Physiol Gastrointest Liver Physiol 294 (2008) G506-G519
73. Bartolazzi A., Nocks A., Aruffo A., et al. Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan. J Cell Biol 132 (1996) 1199-1208
74. Bajorath J. Molecular organization, structural features, and ligand binding characteristics of CD44, a highly variable cell surface glycoprotein with multiple functions. Proteins 39 (2000) 103-111
75. Mikami T., Saegusa M., Mitomi H., et al. Significant correlations of e-cadherin, catenin, and CD44 variant form expression with carcinoma cell differentiation and prognosis of extrahepatic bile duct carcinomas. Am J Clin Pathol 116 (2001) 369-376
76. Xu B., Broome U., Ericzon B.G., et al. High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6. Gut 51 (2002) 120-127
77. He Y., Wu G.D., Sadahiro T., et al. Interaction of CD44 and hyaluronic acid enhances biliary epithelial proliferation in cholestatic livers. Am J Physiol Gastrointest Liver Physiol 295 (2008) G305-G312
78. Alvaro D., Metalli V.D., Alpini G., et al. The intrahepatic biliary epithelium is a target of the growth hormone/insulin-like growth factor 1 axis. J Hepatol 43 (2005) 875-883
79. Drudi Metalli V., Mancino M.G., Mancino A., et al. Bile salts regulate proliferation and apoptosis of liver cells by modulating the IGF1 system. Dig Liver Dis 39 (2007) 654-662
80. Gatto M., Drudi-Metalli V., Torrice A., et al. Insulin-like growth factor-1 isoforms in rat hepatocytes and cholangiocytes and their involvement in protection against cholestatic injury. Lab Invest 88 (2008) 986-994
81. Gil-Pena H., Garcia-Lopez E., Alvarez-Garcia O., et al. Alterations of growth plate and abnormal insulin-like growth factor I metabolism in growth-retarded hypokalemic rats: effect of growth hormone treatment. Am J Physiol Renal Physiol 297 (2009) F639-F645
82. Fouassier L., Rosenberg P., Mergey M., et al. Ezrin-radixin-moesin-binding phosphoprotein (ebp50), an estrogen-inducible scaffold protein, contributes to biliary epithelial cell proliferation. Am J Pathol 174 (2009) 869-880
83. Takeda K., Kojima Y., Ikejima K., et al. Death receptor 5 mediated-apoptosis contributes to cholestatic liver disease. Proc Natl Acad Sci U S A 105 (2008) 10895-10900
84. Sackett S.D., Li Z., Hurtt R., et al. Foxl1 is a marker of bipotential hepatic progenitor cells in mice. Hepatology 49 (2009) 920-929
85. Sackett S.D., Gao Y., Shin S., et al. Foxl1 promotes liver repair following cholestatic injury in mice. Lab Invest 89 (2009) 1387-1396
86. Wang B., Dolinski B.M., Kikuchi N., et al. Role of alphavbeta6 integrin in acute biliary fibrosis. Hepatology 46 (2007) 1404-1412
87. Patsenker E., Popov Y., Stickel F., et al. Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progression. Gastroenterology 135 (2008) 660-670